Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%
Clinical trial NCT02269163 · COMPLETED
Trial details
- NCT number
- NCT02269163
- Sponsor
- Prometic Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-26
- Primary completion
- 2019-01-11
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.